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Diaphragmatic breathing during virtual
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Abstract
Background: Although there is solid evidence for the efficacy of in vivo and virtual reality (VR) exposure therapy for
a specific phobia, there is a significant debate over whether techniques promoting distraction or relaxation have
impairing or enhancing effects on treatment outcome. In the present pilot study, we investigated the effect of
diaphragmatic breathing (DB) as a relaxation technique during VR exposure treatment.
Method: Twenty-nine patients with aviophobia were randomly assigned to VR exposure treatment either with
or without diaphragmatic breathing (six cycles per minute). Subjective fear ratings, heart rate and skin conductance were
assessed as indicators of fear during both the exposure and the test session one week later.
Results: The group that experienced VR exposure combined with diaphragmatic breathing showed a higher tendency to
effectively overcome the fear of flying. Psychophysiological measures of fear decreased and self-efficacy increased in both
groups with no significant difference between the groups.
Conclusions: Our findings indicate that diaphragmatic breathing during VR exposure does not interfere with
the treatment outcome and may even enhance treatment effects of VR exposure therapy for aviophobic
patients.
Trial registration: Retrospectively registered. ClinicalTrials.gov NCT02990208. Registered 07 December 2016.
Keywords: Virtual reality, Exposure therapy, Diaphragmatic breathing, Aviophobia, Experimental study
Background
Up to 40% of the population in industrialized countries
suffers from a fear of flying; another 20% experiences
strong fear during flying [1, 2]. In order to control their
fear, many use coping strategies that include the avoidance
of fear-related situations, self-medication or alcohol [3].
Also, in clinical practice, various coping strategies based
on distraction are commonly used in order to help
patients deal with anxiety-inducing situations [4, 5]. How-
ever, there is a debate amongst researchers whether such
“coping strategies” aiming to reduce fear during treatment
are beneficial for the treatment effect.
For example, avoidance of fear-inducing situations or
trying to distract oneself is considered, by some authors,
to be an adaptive technique for anxious people reacting to
threatening situations [6, 7]. Others hold the opinion that
short-term relief of anxiety by distraction or avoidance is
counterproductive and interferes with effective treatment,
therefore maintaining anxiety in the long term [8, 9]. The
results by Oliver and Page [10] support the assumption
that distraction is an appropriate coping style by showing
a beneficial effect of distraction techniques during in vivo
exposure treatment for participants with a fear of blood,
injections, and/or injury. The participants also displayed
an additional increase of subjective control over their
anxiety during the month following the exposure session.
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Johnstone and Page [11] found that spider phobic patients
who used distraction during treatment showed higher
self-efficacy and subjective control ratings as well as better
performance on behavioral tasks after the exposure treat-
ment. However, as far as the physiological reaction during
distracted exposure is concerned, the authors reported no
difference in blood pressure, heart rate and skin con-
ductance level between the distracted group and the
focused group. In another study, Kamphuis and Telch
[12] examined participants with claustrophobic fears
and found that participants who focused on fear stimuli
in the exposure later demonstrated a lower reoccur-
rence of fear. Although the distraction caused an at-
tenuation of fear during treatment, it did not influence
treatment outcome measures (for a review see [13]).
Available evidence about the effects distraction on
exposure treatment is inconclusive. In their literature
review, Parrish et al. [4] come to the conclusion that
strategies for controlling one’s anxiety can be beneficial
only if it helps to increase self-efficacy and supports
therapeutic change, without diverting attention from the
anxiety-related stimuli during exposure therapy. It is im-
portant to note that in a review by Craske et al. [13], the
authors have not yet found evidence for a relationship
between self-efficacy and treatment effects following
exposure therapy. However, most studies examined used
momentary fear levels during treatment as a dependent
variable and only one used a follow-up test. A recent
meta-analysis by Fentz, Arendt, O'Toole, Hoffart, and
Hougaard [14] also found no studies showing a relation-
ship between panic self-efficacy and treatment effects on
a follow-up test.
In the present study, we aimed to investigate the role
of relaxation as a coping strategy that could increase
self-efficacy during treatment for a fear of flying. Relax-
ation was induced in this study through instructed dia-
phragmatic breathing (DB) during treatment. DB may be
beneficial for exposure therapy since it reduces arousal
on the physiological level [15] but at the same time does
not divert attention from the feared situation to the
same extent as other coping strategies. A few studies
have already implemented DB as a coping strategy with
mixed results. Biggs, Kelly, and Toney [16] compared
the effectiveness of DB vs. focused attention as a coping
strategy in dental phobia. The authors failed to demon-
strate significant differences between the groups, but
found an overall trend in anxiety reduction for all
groups. A related study that investigated the effects of
biofeedback in aviophobia therapy was conducted by
Wiederhold et al. [17]. In this study, both groups were
given instructions on how to use DB and the experimen-
tal group received an additional biofeedback during
treatment. The authors showed that biofeedback had a
positive effect on treatment outcome.
For the treatment protocol, we chose Virtual Reality
Exposure Treatment (VRET) as it is easily controlled
during the exposure and therefore optimal for assessing
various process aspects of exposure therapy. In general,
it has proven effective for the treatment of anxiety (for a
review see the meta-analysis of [18]). Importantly,
former studies have demonstrated the efficacy of our
treatment protocol for a fear of flying [19] even after a
single treatment session [2, 20], as well as the efficacy
for VRET treatment protocols of other researcher
groups ([21]; [22]). Furthermore, VRET is an economic
and safe alternative to in vivo or imagined exposure
when examining fear of flying in participants [23–25].
The present study, designed as an inferiority trial,
investigated the effect of diaphragmatic breathing as an
additional coping strategy during VRET in patients with
aviophobia. We assumed that DB would lead to less fear
and physiological arousal during the VRET and to an
enhanced treatment outcome. In our study, patients with
aviophobia received treatment in VR with or without
DB. Breathing techniques are often used in fear of flying
courses, e.g. in Lufthansa’s seminars for relaxed flying
[26]. We assumed that adding DB to VRET would en-
hance treatment effects by reducing fear during expos-
ure, thus improving the processing of the feared
situation. As a result, self-efficacy should be increased in
comparison to VRET alone.
Methods
Aim
The aim of the study was to investigate the role of a re-
laxation technique, diaphragmatic breathing, as a coping
mechanism during VR exposure therapy of aviophobia.
Participants
From fifty-nine volunteers who had been recruited via
advertisements displayed in public, only thirty (50%
male) fulfilled the inclusion criteria (age 20–65, flying
experience, subjective rating of fear of flying > 60 from
100). Exclusion criteria were pregnancy, heart disease
and current involvement in psychotherapy and/or
pharmacotherapy. One participant in the VRET group
did not complete the treatment and was excluded from
the statistical analyses.
Socio-demographic variables and history of flight
behavior are provided in Table 1. There were no pre-
treatment differences between groups in reference to
socio-demographic characteristics or clinical variables
(except for age). On average, participants in the VRET
group were about 10 years older than the participants
of the VRET + DB group (see Tables 1 and 2).
In each of the groups, one participant did not fulfill all
the criteria for aviophobia (see Table 1). Specifically, these
participants did not feel restricted by their fear in their daily
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lives. They were still included in the study as all other cri-
teria of the specific phobia (flight) were satisfied. The Ethics
Committee of the University of Würzburg approved the
experiment.
Apparatus
The VR environment simulated a passenger compart-
ment of a Boeing 737. Motion simulation was
achieved with the help of a chair on a 6° of freedom
motion platform (Micro-Motion-System, hydraulic,
Krauss–Maffei Wegmann GmbH & Co, Munich,
Germany), a Head Mounted Display (HMD; Virtual
Research HMD V6, Aptos, USA), and a personal
computer. A tracking sensor (Fastrak, Polhemus,
Vermont, USA) assessed the head movements and
updated the field of vision of the HMD. Airplane
sounds and security and breathing instructions were
provided binaurally through headphones (Sennheiser
HD-215, Sennheiser electronic GmbH, Germany).
The HMD refreshing rate was 60 Hz, the VR content
and tracking latencies were in the millisecond range
(<5 ms) [27].
Psychometric Measures
The Flying phobia screening questionnaire (German version
FSB [28]) consists of four subscales measuring possible
exclusion criteria, etiology, previous coping strategies, in-
tensity of fear of flying and avoidance of flying. The re-
ported retest-reliability for a period of two weeks with N =
43 is rtt = .69 [28].
The Structured Clinical Interview for DSM-IV Disorders
(German version SKID [29]) consists of a brief exploration
phase, assessing previous and present symptoms of the
patient followed by a structured interview, in which ten
sections are processed, each concerning a different psy-
chological disorder based on diagnostic criteria by the
Diagnostic and Statistical Manual for mental disorders
IV [30].
The Fear of Flying Scale (FFS; German version FFB
[28]) covers 21 flight situations (e.g., planning the trip,
boarding a plane, turbulence during the flight) rated on
a 5-point Likert scale. Retest-reliability for the period of
three months for the German translation of the FFS is
.90 (N = 120) and a Cronbach’s α of .83 (N = 37) [28]. An
unpublished study confirmed these findings: Cronbach’s
α = .98 (N = 257) and rtt = .87 (N = 43). All these scores
are close to the original FFS indexes of .94 and .86 [31].
The Anxiety Sensitivity Index (ASI [32]) consists of
16 items describing fearful cognitions about anxiety
symptoms rated on a five-point scale. The ASI has a
retest reliability between r = .71 and r = .75 [32]. The
ASI was administered to test pre-treatment differences
between the groups (see Table 2).
Self–efficacy was measured based on two questions
about air travel (question 1: “How confident are you about
flying in a real plane for at least 3 h?” and question 2:”
How confident are you that you would experience only a
moderate level of fear if you travel by plane?”) and was
rated on a 10-point Likert scale (0 = not confident at all,
10 = extremely confident). The questions were adminis-
tered pre and post VR flights in each of the two sessions.
Fear ratings
During the VR flights, patients were asked to rate their
current fear on a scale from 0 (no fear) to 100 (extreme
fear) at four different moments (in the middle of each of
the two turbulence phases and each of the two calm
phases).
Heart rate (HR) and skin conductance level (SCL) were
continuously recorded during the VR flights using a V-
Amp16 amplifier and the Brain Vision Recorder software
(Brain Products GmbH, Gilching, Germany; please see
Shiban et al. [33] for details on the analysis and
recording).
Respiration rate (RR) was measured with the help of a
flexible strap placed around the waist. The RR was re-
corded only in the breathing group with the same setup.
Table 1 Demographic Variables and Diagnoses according to
SCID-1
VRET + breathing VRET
Demographics M SD M SD df t p
Age 34.3 9.81 43 9.96 27 −2.38 .03
N % N % pa
Gender
Female 14 93.3% 10 71.4%
Male 1 6.7% 4 28.6% .17
Diagnoses
Aviophobia 14 93.3% 13 92.9% 1.0
Other specific phobia 9 60.0% 7 50.0% .72
Panic Disorder 2 13.3% 1 7.1% 1.0
Obsessions 0 – 1 7.1% .48
Note. Means, Standard Deviations, df-, t- and p-Values and also quantity and
percentage are given. M mean; SD standard deviation; d degrees of freedom;
VRET Virtual reality exposure therapy; aFisher’s exact test, two-tailed
Table 2 Independent t – tests for baseline scores
VRET + breathing VRET
Questionnaires M (SD) M (SD) df t p
ASI (0–4) 1.35 (.43) 1.28 (.62) 27 0.32 .75
FFS (0–4) 2.65 (.45) 2.35 (.78) 27 1.25 .23
Time spent reading the
information booklet (min.)
45.7 (20.1) 37.9 (27.0) 27 0.89 .33
Note. Means, Standard Deviations in brackets and also df-, t- and p-Values are
given. M mean; SD standard deviation; df degrees of freedom; VRET Virtual
reality exposure therapy; ASI Anxiety Sensitivity Index; FFS Fear of Flying Scale.
T - values show the comparison of means between the VRET + breathing
group and the VRET group before exposure
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Experimental design
Participants were randomly assigned to one of the two
treatment groups: VRET or VRET +DB. Both groups re-
ceived information booklets on aviophobia and exposure
therapy before the beginning of the exposure session.
The VRET group was informed about the importance of
exposure without distraction. The VRET +DB group
received information on diaphragmatic breathing as a
coping strategy during the exposure. One week after the
exposure session, a test session consisting of two flights
took place. A follow up measurement was implemented
after an interval of one year.
Exposure Session
The first meeting lasted 180 min and consisted of the
counseling interview (30 min.) and the exposure session
(three VR flights, 75 min.). The second part of the coun-
seling interview focused on the treatment rationale and
was different for each group.
VRET group
In accordance with the standard procedure for exposure
therapy, participants were asked to focus on their most
anxious thought and/or sensation during each exposure.
VRET + DB group
The relationship between the respiration rate and emo-
tions as well as its relevance for anxiety management
was explained. Diaphragmatic breathing was presented
as a treatment extension that allows fearful patients to
gain control in situations perceived as emotionally un-
controllable. Patients were trained in the technique of
diaphragmatic breathing. They were instructed to take a
breath by contracting the diaphragm and were trained to
maintain their respiration frequency. They were told to
inhale through the nose for four seconds and exhale
through the mouth for six seconds (six cycles per
minute). Patients then had five minutes to practice by
following verbal breathing instructions provided over
headphones.
VR exposure was identical in the VRET group, except
that the VRET +DB group received breathing instruc-
tions over headphones. Each of the three VR flights in
the exposure session lasted 22.5 min. and consisted of
the following phases: start (8 min.) – calm phase 1
(2 min.) – turbulent phase 1 (2 min.) – calm phase 2
(2 min.) – turbulent phase 2 (2 min.) – landing
(6.5 min.).
Test in VR
The test session took place one week after the exposure
session and consisted of two VR flights. The passenger
compartment differed from the one in the exposure ses-
sion in color and, instead of audio security instructions,
instructions now appeared on video. This extended the
duration of the flights by three minutes. Importantly, no
recommendations on breathing were provided.
Each of the VR test flights lasted 25.5 min. and was
identical to the exposure sessions in terms of the order
and duration of the calm and turbulent flight phases.
Procedure
Before the exposure session (pre exposure), patients
received ASI and FFS questionnaires to be filled out at
home. Participants also received the booklet (available
from the authors). After the participants gave their writ-
ten informed consent, the Structured Clinical Interview
for DSM-IV Disorders (German version SKID; [29]) was
conducted.
Patients completed the Self – Efficacy questionnaire.
Then, the electrodes for HR and SCL measurement were
attached. Additionally, a strap for measuring the respira-
tory rate was used (only in the VRET + DB group).
Patients were seated on the motion platform and HMD
and the headphones were adjusted. Participants again re-
ceived either the instruction to focus on the fear (VRET)
or the advice to concentrate on the breathing process
(VRET +DB). Then, the exposure flights took place
(separated by a 5-min break). After the third VR flight,
patients completed the post exposure questionnaires
(FFS, Self-Efficacy). Patients in the VRET + DB group
were requested to practice diaphragmatic breathing as
often as possible until the next session.
One week later, a test session took place in the same
laboratory. Before the session started (pre test), the FFS
and Self-Efficacy questionnaires were filled out. In the
VRET +DB group, the time spent practicing diaphrag-
matic breathing at home was noted. Electrodes were at-
tached and patients were seated on the motion platform
without any further instructions. During the test, two
VR flights took place with a 5-min break between them.
Afterwards, the post test questionnaires (FFS, Self-
Efficacy) were filled in. After an interval of one year, a
postal follow up measurement was implemented using
the same questionnaires (FFS, Self-Efficacy) as those in
the post test session.
Statistical analyses
To test for baseline differences between treatment
groups, t-tests for independent samples were conducted.
Outcome measures (mean FFS scores, Self-Efficacy
scores) were analyzed in separate ANOVAs with the
between-subject factor “group” (VRET +DB, VRET) and
the within-subject factor “time” (pre exposure, post
exposure, pre test, post test and follow up). The process
measures (Fear ratings, HR, SCL) were analyzed using
mixed ANOVAs with a repeated-measures design with
the between-subject factor “group” (VRET +DB, VRET)
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and the within-subject factors “flight” (exposure: flight 1,
flight 2, flight 3) and “phase” (calm 1, turbulent 1, calm
2, turbulent 2). The significance level was set at α = .05.
Significant effects in the ANOVAs were followed up by
t-tests. Greenhouse-Geisser correction was administered




As we can see in Fig. 1, there was a drop in the participants’
fear of flying in the course of the exposure and test sessions,
which was supported by a significant main effect of time
(F2.80, 64.39 = 38.17, p ≤ .001, ηp
2 = .62). Furthermore, a mar-
ginally significant interaction Time x Group (F2.80, 64.39 =
2.70, p = .057, ηp
2 = .11) was evident. Follow-up t-tests of the
within-subjects factor time revealed a significantly greater
decrease in fear of flying from pre exposure [M = 2.47, SD
= 0.68] to the rest of the measurements (post exposure [M
= 1.59, SD = 0.78], pre test [M = 1.59, SD = 0.72], post test
[M = 1.09, SD = 0.72], and follow up [M = 1.72, SD = 0.76]
all p’s < .001).
Excluding two participants older 55 years of age, there
was still a significant main effect of time (F2.74, 57.47 = 32.93,
p ≤ .001, ηp
2 = .61). Furthermore, a significant interaction
Time x Group (F2.74, 57.47 = 3.83, p = .017, ηp
2 = .15) was
evident. Follow-up t-tests of the within-subjects factor time
revealed a significantly greater decrease of fear of flying
from pre exposure [M = 2.52, SD = 0.67] to the rest of the
measurements (post exposure [M = 1.70, SD = 0.71], pre
test [M = 1.69, SD = 0.66], post test [M = 1.17, SD = 0.68],
and follow up [M = 1.77, SD = 0.75] all p’s < .001).
Self-efficacy
As shown in Fig. 2, there was an increase in self-efficacy
over time in both groups, which corresponds to a
significant main effect of time (F2.67, 64.13 = 25.26, p
< .001, ηp
2 = .51). No effect involving the factor group was
significant.
Excluding the two participants aged above 55 there
was a significant main effect of time as well (F2.55, 56.04 =
23, 07, p < .001, ηp
2 = .51). No effect involving the factor
group was significant.
Process analysis during exposure session
Self-reported fear
Figure 3 shows that fear ratings changed within flights
(depending on the flight phase) and between flights.
These changes are indicated by significant main effects
of flight (F1.20, 32.26 = 26.31, p = < .001, ηp
2 = .49), phase
(F1.85, 49.95 = 23.26, p < .001, ηp
2 = .46), and a significant
Flight x Phase interaction (F3.98, 107.48 = 4.52, p < .001 ηp
2
= .14). Group differences were not significant. To further
analyze the Flight x Phase interaction, we conducted
three separate repeated measures ANOVAs for the three
flights. These ANOVAs revealed a significant main effect
of phase in all flights (first: F2.40, 67.06 = 13.67, p < .001,
ηp
2 = .33; second: F1.63, 45.62 = 25.70, p < .001, ηp
2 = .48;
third: F2.36, 66.04 = 12.90, p < .001, ηp
2 = .32). Further t-tests
for the first flight showed that all pairs were significant
(p < .05), except two pairs (c1/c2: p = .160, t1/t2: p
= .120). In the second flight, all pairs reached signifi-
cance (p < .05) and in the third flight all except c1/t2 (p
= .861) did as well.
Excluding the two old participants, there were signifi-
cant main effects of flight (F1.22, 30.58 = 20.84, p = < .001,
ηp
2 = .46), phase (F1.73, 43.13 = 23.40, p < .001, ηp
2 = .48), and
a significant Flight x Phase interaction (F6, 150 = 4.24, p
= .001, ηp
2 = .15). Group differences were not significant.
Repeated measures ANOVAs for the three flights
revealed a significant main effect of phase in all flights
(first: F2.26, 58.82 = 16.99, p < .001, ηp


















Fig. 1 Questionnaire ratings of the Fear of Flying Scale (FFS). Note.
VRET = Virtual reality exposure therapy, DB = diaphragmatic breathing.
Graphs represent the mean of the questionnaire ratings of the FFS for
the five measurements for both groups (VRET +DB: N = 15, VRET: N= 14):
pre exposure, post exposure, pre test (one week after exposure session),
post test and follow up (after one year, VRET +DB: N= 12, VRET: N= 13).

























Fig. 2 Self-efficacy scores. Note. VRET = Virtual reality exposure therapy,
DB = diaphragmatic breathing. Graphs represent the mean of the self-
efficacy scores for the five measurements for both groups (VRET + DB:
N = 15, VRET: N = 14): pre exposure, post exposure, pre test (one week
after exposure session), post test and follow up (after one year, VRET +
DB: N = 12, VRET: N = 14). Standard errors are represented as error bars
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40.62 = 23.51, p < .001, ηp
2 = .48; third: F2.37, 61.53 = 12.82, p
< .001, ηp
2 = .33).
Further t-tests for the first flight showed that all pairs
were significant (p < .05). In the second flight, all pairs
reached significance as well (p < .05) and in the third
flight all except c1/t2 (p = .862).
Heart rate (HR)
As demonstrated in Fig. 4, HR decreased both within
and between flights. These patterns were partially
confirmed by the statistical analysis. ANOVA revealed
significant main effects of the factor flight (F1.41, 38.05 =
17.13, p < .001, ηp
2 = .39), phase (F2.13, 57.42 = 14.41, p
< .001, ηp
2 = .35), and a Flight x Phase interaction (F2.57,
69.26 = 4.95, p < .001, ηp
2 = .16). No other effects were
significant. We conducted three separate repeated mea-
sures ANOVAs for the three flights to follow up on the
interaction. We conducted three separate repeated mea-
sures ANOVAs for the three flights to follow up on the
interaction. These ANOVAs revealed a significant main
effect of phase in all three flights (first: F2.04, 57.08 = 9.52,
p < .001, ηp
2 = .25; second: F2.22, 62.13 = 13.65, p < .001, ηp
2
= .33; third: F2.31, 64.73 = 4.60, p = .010, ηp
2 = .14). Further
t-tests for the first flight showed that all pairs were sig-
nificant (p < .05), except the pair (c1/t2: p = .512). In the
second flight, all pairs reached significance (p < .05), ex-
cept one pair that was marginally significant (c1/c2: p
= .057). In the third flight, only 4 out of 6 pairs were sig-
nificant (p < .05; c1/c2: p = .686, t1/t2: p = .237).
Excluding the two older participants, an ANOVA re-
vealed significant main effects of the factor flight (F1.41, 35.30
= 15.92, p < .001, ηp
2 = .39), phase (F2.09, 52.19 = 13.32, p
< .001, ηp
2 = .35), and a Flight x Phase interaction (F2.46, 61.50
= 5.06, p < .001, ηp
2 = .17). No other effects were significant.
We conducted three separate repeated measures ANOVAs
for the three flights to follow up on the interaction. These
ANOVAs revealed a significant main effect of phase in all
three flights (first: F2.04, 52.99 = 9.45, p < .001, ηp
2 = .27; sec-
ond: F2.21, 57.40 = 13.29, p < .001, ηp
2 = .34; third: F3. 78 = 3.96,
p = .011, ηp

























c1 t1 c2 t2 c1 t1 c2 t2





Fig. 3 Fear ratings during the exposure (3a) and test session (3b). Note. VRET = Virtual reality exposure therapy, DB = diaphragmatic breathing,
c1/c2 = calm, t1/t2 = turbulence. Graphs represent the mean of the fear ratings during the exposures (1–3) and the test sessions (1–2) for both
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Fig. 4 Heart rate (HR) during the exposure (4a) and test session (4b). Note. VRET = Virtual reality exposure therapy, DB = diaphragmatic breathing,
c1/c2 = calm, t1/t2 = turbulence. Graphs represent the mean of the heart rate during the exposures (1–3) and the test sessions (1–2) for both
groups. Standard errors are represented as error bars
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that all pairs were significant (p < .05), except the pair
(c1/t2: p = .533). In the second flight, all pairs reached
significance (p < .05), except one pair that was margin-
ally significant (t1/t2: p = .055). In the third flight, only
4 out of 6 pairs were significant (p < .05; c1/c2: p = .651,
t1/t2: p = .393).
Skin conductance level (SCL)
As shown in Fig. 5, SCL remained relatively stable
during the three VR exposure flights. ANOVA re-
vealed significant main effects of phase (F1.76, 47.47 =
6.64, p = .004, ηp
2 = .20) No other effects were signifi-
cant. A follow-up analysis of the three flights separ-
ately showed a significant main effect of phase for
the first and second flights (first: F1.34, 37.47 = 4.85, p
= .024, ηp
2 = .15; second: F2.30, 64.27 = 5.66, p = .004, ηp
2
= 0.17), but not for the third flight (p = .384). Follow
up t-tests showed that in the first flight all pairs ex-
cept two (c1/t2: p = .375, c2/t2: p = .503) were signifi-
cant. Similarly, in the second flight we could see the
same pattern (c1/t1: p = .155, c1/t2: p = .435). This
indicates that the turbulence manipulation was still
influential within the first two flights but not in the
third flight.
Excluding the older participants, ANOVA revealed
significant main effects of phase (F1.76, 44. 06 = 6.02,
p = .007, ηp
2 = .19) No other effects were significant. A
follow-up analysis of the three flights separately
showed a significant main effect of phase for the
first and second flight (first: F1.31, 34.07 = 5.13, p
= .022, ηp
2 = .17; second: F2.33, 60.66 = 5.45, p = .005, ηp
2
= .17), but not for the third flight (p = .493).
Follow up t-tests showed that in the first flight all
pairs except two (c1/t2: p = .329, c2/t2: p = .475) were
significant. Similarly, in the second flight we could
see the same pattern (c1/t1: p = .225, c1/t2: p = .282).
Test flights in VR
Self-reported fear
The fear ratings changed within flights—depending on
the flight phase—and between flights. These changes are
indicated by significant main effects of flight (F1.27 =
45.29, p < .001, ηp
2 = .63) and phase (F1.40, 37.90 = 17.40, p
< .001, ηp
2 = .39). Excluding the two participants aged >
55, there was an effect of flight (F1,25 = 45.90, p < .001,
ηp
2 = .65) and phase (F1.40, 34.99 = 17.51, p < .001, ηp
2 = .41).
Heart rate (HR)
The HR decreased both within and between flights during
the test flights. These patterns are partially reflected in the
statistical analysis. The ANOVA revealed a significant
main effect of flight (F1, 27 = 4.82, p = .037, ηp
2 = .15) and a
Flight x Phase interaction (F1.73, 46.59 = 5.84, p = .008, ηp
2
= .18). To follow up on the interaction, we conducted two
ANOVAs, one for each flight with phase as the within
subject factor. Only the first flight phase was marginally
significant (F1.31, 36.54 = 3.52, p = .058, ηp
2 = .11). The t-tests
within the first phase showed a significant difference or
marginally significant differences between t2 and c1 (p
= .051), t1 (p = .038) and c2 (p = .068) and a marginally sig-
nificant difference between t1 and c2 (p = .058).
Excluding the two older participants, the ANOVA
revealed no significant main effect of flight (p = .074) but
a Flight x Phase interaction (F1.72, 43.01 = 5.40, p = .011,
ηp
2 = .18). To follow up on the interaction, we conducted
two ANOVAs, one for each flight with phase as the
within subject factor. Neither for the first (p = .079) nor
for the second (p = .104) flight there was a significant
effect of phase.
Skin conductance level (SCL)
The SCL remained relatively stable during the test
flights. No significant differences were observed (a
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Fig. 5 Skin conductance level (SCL) during the exposure (5a) and test sessions (5b). Note. VRET = Virtual reality exposure therapy, DB = diaphragmatic
breathing, c1/c2 = calm, t1/t2 = turbulence. Graphs represent the mean of the SCL during the exposures (1–3) and the test sessions (1–2) for both
groups. Standard errors are represented as error bars
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3.04, p = .093, ηp
2 = .11)). Excluding the two participants
older than 55 there were no significant differences.
Relation between self-efficacy and fear of flying
Table 3 shows the correlations between self-efficacy (pre
exposure, post test, and self-efficacy change, i.e. the dif-
ference in self-efficacy score between pre exposure and
post test) with FFS pre exposure and post test levels and
FFS reduction (pre exposure – Test). A significant nega-
tive correlation between self-efficacy post test and the
FFS score post test was discovered (r = −.77, p < .001).
However, there was no significant correlation between
self-efficacy change and reduction in the FFS in either
group.
Excluding two participants older than 55 years of age
there was a significant negative correlation between self-
efficacy post test and the FFS score post test both in the
VRET group (r = −.73, p = .007) and in the VRET +
breathing group (r = −.54, p = .039). Furthermore,
there was a significant negative correlation between
self-efficacy pre exposure and both the baseline FFS
score (r = −.68, p = .015) and the FFS score post test (r
= −.60, p = .038) in the VRET group. Furthermore,
there was a significant correlation between the self-
efficacy change and the FFS baseline score in the
VRET + breathing group (r = .55, p = .033). Apart from
that there were no significant correlations between
self-efficacy (pre exposure, post test, and self-efficacy
change) and the FFS scores (pre exposure and post
test levels and FFS reduction).
Manipulation check
Respiratory frequency
Descriptive analyses indicated that patients in the VRET
+DB group were able to maintain the learned breathing
frequency (four seconds inhale - six seconds exhale, six
cycles per minute). Patients were instructed to practice
diaphragmatic breathing between exposure and test ses-
sions. According to their reports, patients practiced on
average 4.93 times (SD = 2.29), with a mean practice
time of 8.67 min (SD = 4.43). Importantly, even without
verbal instruction, patients continued to keep their
breathing rhythm at 6 cycles per minute (mean breath
duration was 9.88 (SD = 0.91) and 10.35 (SD = 2.1) in the
exposure and test sessions, respectively).
Discussion
The present study investigated the effect of diaphrag-
matic breathing as an additional coping strategy during
VRET in patients with aviophobia. A significant reduc-
tion of fear of flying was confirmed by the FFS measures
in both groups. As predicted, this reduction in fear of
flying was more evident in the VRET + DB group than in
the VRET group, although at trend level only. These
results support the hypothesis that actions that could be
considered to represent distraction – in this case DB, a
relaxation exercise – do not necessarily have a negative
impact on treatment efficacy.
Our findings correspond with the results reported by
Milosevic and Radomsky [34], who investigated the
effects of safety equipment during exposure treatment
for snake-fearful participants. The authors discovered
that safety equipment did not reduce treatment effects.
Similar results were reported by Johnstone and Page
[11]: patients with spider-phobia who were engaged in a
distracting conversation during treatment showed better
treatment effects compared to patients that had to main-
tain a focused conversation during the exposure. Jones
and Menzies [35] found that coping strategies could
enhance self-efficacy.
As expected, VRET with and without DB resulted in a
significant reduction of subjective fear ratings and HR
during exposure therapy as well as during the second
exposure session, which did not include a therapist’s
guidance. It is noteworthy that subjective fear ratings
and HR continued to decrease during the test session
without a therapist’s guidance, which implies that after
just one session of exposure treatment patients with
aviophobia were able to benefit from the therapy. In the
VRET +DB group, the patients showed a high level of
compliance with the rhythm trained in session 1 without
any additional auditory breathing instructions, which in-
dicates that patients can learn diaphragmatic breathing
in only one session.
Regarding psychophysiological process variables, we
found HR decreased in all exposure trials, while SCL
remained constant throughout most exposure trials,
reacting only at the onset (flight 1) of turbulence. A
possible explanation for this result could be the course
of the exposure session with turbulences during the
flight and accelerations and decelerations during start
and landing, which might have impeded or oversha-
dowed habituation. Similarly, in a study on virtual reality
Table 3 Correlation of self-efficacy with FFS
FFS BL FFS post FFS reduction
VRET + breathing
self-efficacy pre exposure -.50 -.45 .08
self-efficacy post test -.16 -.54* .47
self-efficacy change .55* .18 -.26
VRET
self-efficacy pre exposure -.61* -.35 -.25
self-efficacy post test -.42 -.77** .42
self-efficacy change .14 -.34 -.52
Note. Correlation of self-efficacy (pre session 1, post session 2, and self-efficacy
change) with FFS at baseline (BL), after the test session (post) and FFS reduction
(BL – post) are given. FFS Fear of Flying Scale; **p < .01; *p < .05
Shiban et al. BMC Psychiatry  (2017) 17:29 Page 8 of 10
exposure to heights which also involved repeated
stressors (looking down) during exposure there was no
habituation of the SCL either [36]. SCL is sensitive to
novelty and would probably only have decreased steadily
if the flights during the exposure were calm, which was
not the case in this study. However, the fact that during
the third of the three flights, turbulences no longer
increased SCL indicates a desensitization effect to turbu-
lences. Both HR and fear ratings increased during turbu-
lent flight phases, which corresponds with the findings
of Trimmel, Burger, Langer, and Trimmel [37].
Bandura [38] showed that social cognition theory empha-
sizes self-efficacy with regards to coping with threatening
situations as the key to therapeutic change. No significant
differences in self-efficacy were evident in our study
between the groups. This corresponds with the conclusions
from Craske et al. [13], in that an increase in self-efficacy
may not be the mechanism underlying the better response
of the VRET+DB group to the treatment. Rather a com-
bination of cognitive and physiological factors may account
for the enhanced treatment effects in the VRET+DB
group. With respect to cognitive processes, a possible
underlying mechanism could be an increase in the percep-
tion of control: By attentively influencing their breathing,
patients feel like they have control over their body, which
reduces the feeling of helplessness usually experienced
while anxious [39]. In following studies, the effect of
perceived control over the situation while undergoing
VRET should be investigated. As far as physiological factors
are concerned, diaphragmatic breathing can lead to muscle
relaxation, decreased arousal of the autonomic nervous
system and a slower heart rate [15]. The reduced level of
arousal might enhance extinction learning.
Some limitations to this study should be taken into
account. First, there are different types of aviophobia
[40], which we did not assess. Therefore, we did not test
whether our VR therapy protocol is adequate for all
types of aviophobia. Second, we only investigated a limited
number of participants in this pilot study (n = 29) and
therefore the power of our study is low1. Further studies
have to confirm the results of our current study. This could
possibly explain non-significant results. Concerning the
calculations of initial fear activation, we did not collect
baseline data for HR and SCL, but instead used the last two
minutes before the landing of the third flight, assuming that
physiological arousal had reached its baseline level again.
Moreover, there was a difference of about 10 years in age
between the two groups. However, we are not aware of any
studies indicating a relationship between age and treatment
effects for aviophobia. Moreover, our participants did not
differ in treatment-relevant variables such as initial fear
ratings. Another important limitation is the fact that
participants’ avoidance and fear post-treatment was
only assessed under virtual reality test conditions and
not on actual airplanes. In order to generalize the
observed treatment effects to real flying, a follow-up in-
vestigating treatment outcome with flights on actual
airplanes would be necessary.
Finally, being a pilot study, the experiment was con-
ducted with a limited number of participants. Neverthe-
less, our results indicated that DB may be a beneficial
supplement for VR exposure therapy in aviophobics.
Further research including larger samples will be needed
in order to confirm this view.
Conclusion
In conclusion, the present study provides additional
evidence for the effectiveness of VR exposure therapy
as a treatment for aviophobia. Importantly, our results
indicate that using diaphragmatic breathing as an add-
itional strategy to VR exposure could possibly lead to
higher reductions in fear of flying compared to VR ex-
posure alone. Further studies should analyze whether
this effect is specific to aviophobia, or if it is encoun-
tered in other anxiety disorders (e.g., panic disorder)
as well.
Endnotes
1According to post hoc power analysis a total sample
size of N = 36 (with power of 0.8 and the observed effect
size for the interaction) would have resulted in a signifi-
cant effect.
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